Glucagon-like peptide 1 (GLP-1) analogs are increasingly being used in the treatment of type 2 diabetes. It is clear that these drugs lower blood glucose through an increase in insulin secretion and a lowering of glucagon secretion; in addition, they lower body weight and systolic blood pressure and increase heart rate. Using a new monoclonal antibody for immunohistochemistry, we detected GLP-1 receptor (GLP-1R) in important target organs in humans and monkeys. In the pancreas, GLP-1R was predominantly localized in β-cells with a markedly weaker expression in acinar cells. Pancreatic ductal epithelial cells did not express GLP-1R. In the kidney and lung, GLP-1R was exclusively expressed in smooth muscle cells in the walls of arteries and arterioles. In the heart, GLP-1R was localized in myocytes of the sinoatrial node. In the gastrointestinal tract, the highest GLP-1R expression was seen in the Brunner's gland in the duodenum, with lower level expression in parietal cells and smooth muscle cells in the muscularis externa in the stomach and in myenteric plexus neurons throughout the gut. No GLP-1R was seen in primate liver and thyroid. GLP-1R expression seen with immunohistochemistry was confirmed by functional expression using in situ ligand binding with (125)I-GLP-1. In conclusion, these results give important new insight into the molecular mode of action of GLP-1 analogs by identifying the exact cellular localization of GLP-1R.
Pubmed ID: 24467746 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Glucagon-like peptide 1 receptor
View all literature mentionsThis polyclonal targets Glucagon
View all literature mentionsThis polyclonal targets CBLB antibody produced in rabbit
View all literature mentionsThis unknown targets anti Insulin
View all literature mentionsThis monoclonal targets Insulin (C27C9) Rabbit mAb
View all literature mentionsThis polyclonal targets REN
View all literature mentionsThis polyclonal targets alpha smooth muscle Actin
View all literature mentionsThis polyclonal targets Cytokeratin 19
View all literature mentionsThis polyclonal targets Synthetic human calcitonin, aa 1-32, coupled to bovine serum albumin (BSA)
View all literature mentionsThis unknown targets Hyperpolarization-Activated Cyclic Nucleotide-Gated Potassium Channel 4
View all literature mentionsThis polyclonal targets Pancreatic Polypeptide
View all literature mentions